Company patents
CARDIOVALVE LTD.
CARDIOVALVE LTD. exhibits an almost exclusive focus on Implants & Prosthetics, which constitutes 97.1% of its patent portfolio, yet this core area has seen a significant decline in patenting activity, with a 50.0% drop in 2025 and an 84.6% drop so far in 2026. This suggests a potential shift away from aggressive patenting in its primary domain, or a maturation of its core technology, despite its name implying a continued focus on cardiovascular implants.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
70 US filings (since 2023) · 7 categories · 3 themes
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Patents
Showing 1-1 of 1
Catheter-based Intervention Devices